- Home
- EB vs NGNE Comparison
EB vs NGNE Comparison
Compare EB & NGNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EB
- NGNE
- Stock Information
- Founded
- EB 2008
- NGNE 2003
- Country
- EB United States
- NGNE United States
- Employees
- EB N/A
- NGNE N/A
- Industry
- EB EDP Services
- NGNE Biotechnology: Pharmaceutical Preparations
- Sector
- EB Technology
- NGNE Health Care
- Exchange
- EB Nasdaq
- NGNE Nasdaq
- Market Cap
- EB 341.0M
- NGNE 352.4M
- IPO Year
- EB 2018
- NGNE N/A
- Fundamental
- Price
- EB $3.54
- NGNE $16.60
- Analyst Decision
- EB Buy
- NGNE Strong Buy
- Analyst Count
- EB 6
- NGNE 6
- Target Price
- EB $6.70
- NGNE $60.80
- AVG Volume (30 Days)
- EB 998.5K
- NGNE 223.3K
- Earning Date
- EB 02-25-2025
- NGNE 11-18-2024
- Dividend Yield
- EB N/A
- NGNE N/A
- EPS Growth
- EB N/A
- NGNE N/A
- EPS
- EB N/A
- NGNE N/A
- Revenue
- EB $336,368,000.00
- NGNE $925,000.00
- Revenue This Year
- EB $2.57
- NGNE N/A
- Revenue Next Year
- EB $4.11
- NGNE N/A
- P/E Ratio
- EB N/A
- NGNE N/A
- Revenue Growth
- EB 8.54
- NGNE N/A
- 52 Week Low
- EB $2.51
- NGNE $14.44
- 52 Week High
- EB $9.20
- NGNE $74.49
- Technical
- Relative Strength Index (RSI)
- EB 52.65
- NGNE 29.73
- Support Level
- EB $3.38
- NGNE $17.63
- Resistance Level
- EB $3.73
- NGNE $20.29
- Average True Range (ATR)
- EB 0.15
- NGNE 1.56
- MACD
- EB 0.01
- NGNE -0.15
- Stochastic Oscillator
- EB 63.46
- NGNE 5.29
About EB Eventbrite Inc.
Eventbrite Inc is a self-service ticketing and experience technology platform that serves event creators. It is engaged in creating a platform to enable creators to solve many challenges associated with creating live experiences. The Company's platform integrates components needed to seamlessly plan, promote and produce live events. Its platform helps to plan, promote and produce live events, thereby allowing creators to reduce friction and costs, increase reach and drive ticket sales. Geographically, it generates maximum revenue from the United States.
About NGNE Neurogene Inc.
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.